Septerna Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Septerna Inc
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.
/ 
Frequently asked questions
To buy Septerna Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Septerna Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Septerna Inc is SEPN:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Septerna Inc has its primary listing on NASDAQ. You can trade Septerna Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Septerna Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Septerna Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Septerna Inc.